Clinicopathologic Features of Late Onset Veno-Occlusive Disease/Sinusoidal Obstructive Syndrome After High Dose Busulfan and Hematopoietic Cell Transplantation

Ítems similars

• Phase I study of dose-escalated busulfan with fludarabine and alemtuzumab as conditioning for allogeneic hematopoietic stem cell transplant: reduced clearance at high doses and occurrence of late sinusoidal obstruction syndrome/veno-occlusive disease
  per: O’DONNELL, PETER H., et al.
  Publicat: (2010)
• Sinusoidal Obstruction Syndrome (Hepatic Veno-Occlusive Disease)
  per: Fan, Cathy Q., et al.
  Publicat: (2014)
• The Early Sinusoidal Lesion in Experimental Veno-Occlusive Disease of the Liver
  per: McLean, Elizabeth K.
  Publicat: (1969)
• Hepatic veno-occlusive disease/sinusoidal obstruction syndrome after hematopoietic stem cell transplantation for thalassemia major: incidence, management, and outcome
  per: Lai, Xiaoxuan, et al.
  Publicat: (2021)
• Defibrotide for the treatment of hepatic veno-occlusive disease/sinusoidal obstruction syndrome with multiorgan failure
  per: Richardson, Paul G, et al.
  Publicat: (2017)